Financial record ------------------------- Annual report 2000 - contents ------------------------- Financial summary ------------------------- Joint statement by the Chairman & the CEO ------------------------- Description of business ------------------------- Corporate Governance ------------------------- Remuneration Report ------------------------- Operating & Financial Review & Prospects ------------------------- Directors' statements of responsibility ------------------------- Report by the auditors ------------------------- Consolidated statement of profit & loss ------------------------- Consolidated statement of total recognised gains & losses ------------------------- Consolidated statement of cash flow ------------------------- Consolidated balance sheet ------------------------- Reconciliation of movements in equity shareholders' funds ------------------------- Company balance sheet ------------------------- Notes to financial statements ------------------------- Group companies ------------------------- Principal financial statements in US$ ------------------------- Financial record ------------------------- Shareholder Return ------------------------- Taxation information for shareholders ------------------------- Shareholder information ------------------------- Share capital ------------------------- Cross reference to Form 20-F ------------------------- Glossary of terms ------------------------- Contact details

		Quarterly trend
			An analysis is provided by quarter of the Group results in sterling for the financial year 2000. The analysis is of: business performance results; total results; pharmaceutical sales by therapeutic area.
			• Profit and loss account - business performance and total results
			• Pharmaceutical sales - Total Group
			• Pharmaceutical sales - USA
			• Pharmaceutical sales - Europe
			• Pharmaceutical sales - Rest of World
		Five-year record
	Updated March 22, 2001 - © 2001-2002 GlaxoSmithKline - All Rights Reserved Legal Notices - Privacy Statement